Abstract
A double-blind, placebo-controlled investigation has been made into the effects of 8 weeks of glipizide treatment in diabetics previously classified as Type 2 but with subsequent attenuation of insulin secretion and thence maintained on exogenous insulin. Although all patients were exposed to therapeutic plasma concentrations of glipizide, fasting blood glucose, haemoglobin A1 and plasma lipoproteins (HDL, LDL, total cholesterol and triglycerides) did not show any consistent improvement following this treatment. It appears unlikely that SU (glipizide) has any primary effect on insulin action or on plasma lipoproteins. Its primary action is to augment insulin release and availability, so, its use should be restricted to Type 2 diabetics who retain insulin secretion.
References
Apr 1, 1978·Scandinavian Journal of Clinical and Laboratory Investigation·B DanielssonJ Wadstein
Dec 1, 1979·Journal of Chromatography·E Wåhlin-Boll, A Melander
Jul 8, 1978·Lancet·G D CalvertR A Yeates
Mar 1, 1979·Acta Endocrinologica·H Beck-NielsenH O Lindskov
Jun 1, 1978·Atherosclerosis·B V HowardP H Bennett
Jan 1, 1976·The American Journal of Medicine·G M ReavenJ M Olefsky
Sep 1, 1977·The Journal of Clinical Endocrinology and Metabolism·H E LebovitzF L Lebovitz
Mar 1, 1975·The Journal of Clinical Investigation·H GinsbergG M Reaven
Dec 1, 1975·Diabetologia·L G Heding
Jan 1, 1986·European Journal of Clinical Pharmacology·E Wåhlin-BollA Melander
Jan 1, 1985·European Journal of Clinical Pharmacology·L GroopF Fyhrqvist
Jan 1, 1984·European Journal of Clinical Pharmacology·A J ScheenA S Luyckx
Nov 30, 1983·The American Journal of Medicine·A Melander, E Wåhlin-Boll
Dec 1, 1984·The American Journal of Medicine·K OseiJ M Falko
Feb 1, 1981·Diabetologia·H J Lisch, S Sailer
Jan 1, 1980·Diabetologia·S E Fineberg, S H Schneider
May 1, 1980·Diabetes·M A PfeiferD Porte
Jan 1, 1980·Annual Review of Biochemistry·P Nilsson-EhleM C Schotz
Sep 1, 1981·Drugs·J E Jackson, R Bressler
Jan 1, 1981·Acta Medica Scandinavica·S MadsbadC Binder
Oct 1, 1981·Drugs·J E Jackson, R Bressler
Jan 1, 1982·Diabetologia·M R TaskinenK Harmo
Jan 1, 1982·European Journal of Clinical Pharmacology·L O AlmérE Wåhlin-Boll
Jul 1, 1982·Clinical Pharmacokinetics·E Wåhlin-BollA Melander
Jan 1, 1957·Bulletin médical·P BERTHAUX
Jul 10, 1957·Annals of the New York Academy of Sciences·A LOUBATIERES
Citations
Jan 1, 1992·European Journal of Clinical Pharmacology·P O BitzénE Wåhlin-Boll
Apr 16, 2005·Heart·D A StakosH Boudoulas
Oct 9, 2002·Current Medical Research and Opinion·Jeannette M Goguen, Lawrence A Leiter